Answer
Prasugrel hydrochloride, co-administered with acetylsalicylic acid (ASA), prevents atherothrombotic events in adults with acute coronary syndrome (unstable angina, NSTEMI or STEMI) undergoing primary or delayed percutaneous coronary intervention.
Sources for this answer
- Prasugrel 5 mg film-coated tabletsMSN Laboratories Europe Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 1Document updated
Sources checked